We are serial entrepreneurs using a unique model to discover and nurture ground-breaking ideas for therapeutic medical devices.
We create and build companies to turn the best of these ideas into tools that practitioners can use to save and improve patients’ lives.
|2008||MD Start I||€8.2 million|
|2015||MD Start II||€10.3 million|
|2019||Sofinnova MD Start III||€63 million|
Fund: MD Start I
AMT: €8.2 million
Fund: MD Start II
AMT: €10.3 million
Fund: Sofinnova MD Start III
AMT: €63 million
“We’re not trying to find ways to use new technologies in medicine. We start from the clinical need. From there, we try to find technologies that will help us develop products that are going to solve that need.”
"We're not up there in the balcony giving the thumbs up or thumbs down as entrepreneurs make their pitches. We build the story; we bring in the necessary assets; we create the company, often from scratch."
LimFlow raises $40 million (€36 million) in Series D financing
SafeHeal announces successful launch of pivotal study for Colovac endoluminal bypass sheath
CorWave to set up its manufacturing facility and expand to a new site next to Paris
"We build them to be great companies," Anne Osdoit tells In Vivo
SafeHeal closes €40 million financing co-led by Sofinnova Partners and Genesis MedTech to finance its Colovac device through a pivotal clinical trial in the United States